ArticleActive
Response to Comments: Allergen Immunotherapy
A59574
Novitas Solutions, Inc. (J12)
Effective: February 15, 2024
Updated: December 31, 2025
Policy Summary
This document contains summaries of comments and contractor responses related to Novitas Solutions Proposed LCD DL36240 (Allergen Immunotherapy) and does not present standalone clinical coverage criteria. For specific indications, limitations, documentation requirements, and frequency limits, review the final LCD DL36240 referenced in this response-to-comments document.
Coverage Criteria Preview
Key requirements from the full policy
"This document is a summary of public comments and contractor responses for Novitas Solutions Proposed LCD DL36240 (Allergen Immunotherapy) and does not itself define clinical coverage criteria; ref..."
Sign up to see full coverage criteria, indications, and limitations.